Home/Filings/4/0001209191-20-013408
4//SEC Filing

Kowalski Mark 4

Accession 0001209191-20-013408

CIK 0001290149other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:16 PM ET

Size

5.7 KB

Accession

0001209191-20-013408

Insider Transaction Report

Form 4
Period: 2020-02-25
Kowalski Mark
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-02-25+75,03075,030 total
    Exercise: $13.31Exp: 2030-02-25Common Stock (75,030 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the total shares on February 25, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 25, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Sierra Oncology, Inc.

CIK 0001290149

Entity typeother

Related Parties

1
  • filerCIK 0001628357

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:16 PM ET
Size
5.7 KB